相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
Andrew Dunbar et al.
BLOOD (2021)
Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With Cancer
Jiasheng Wang et al.
MAYO CLINIC PROCEEDINGS (2021)
Venous thromboembolism in cancer patients: a population-based cohort study
F. Mulder et al.
BLOOD (2021)
Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation
Lena Hell et al.
CANCERS (2021)
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles
Nadim Tawil et al.
BLOOD ADVANCES (2021)
Anaplastic lymphoma kinase rearrangement may increase the incidence of venous thromboembolism by increasing tissue factor expression in advanced lung adenocarcinoma
Sen Yang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Longitudinal analysis of extracellular vesicle-associated tissue factor activity in cancer patients
Eva-Maria Reitter et al.
THROMBOSIS RESEARCH (2020)
Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer
Raj S. Kasthuri et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial
Johann S. de Bono et al.
LANCET ONCOLOGY (2019)
Disseminated Intravascular Coagulation in Cancer: An Update
Marcel Levi
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis
Yohei Hisada et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
Anastasios Gkountakos et al.
CANCERS (2019)
Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo
Konstantin Stark et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
Gary H. Lyman et al.
THROMBOSIS RESEARCH (2018)
Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study
Nick van Es et al.
THROMBOSIS RESEARCH (2018)
Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients
Yohei Hisada et al.
THROMBOSIS RESEARCH (2018)
Mouse models of cancer-associated thrombosis
Yohei Hisada et al.
THROMBOSIS RESEARCH (2018)
Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON
Zhiwei Hu et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Treating Tissue Factor-Positive Cancers with Antibody-Drug Conjugates That Do Not Affect Blood Clotting
Jan-Willem Theunissen et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Expression of tissue factor in human cervical carcinoma tissue
Xitong Zhao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin
E. Gezelius et al.
PLOS ONE (2018)
Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer
Joshua G. Cohen et al.
GYNECOLOGIC ONCOLOGY (2017)
Tissue Factor: Catch Me If You Can!
Cihan Ay et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size
Y. Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma
Xuesai Zhang et al.
ONCOTARGET (2017)
Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells via Protease-Activated Receptor-1
Sara P. Y. Che et al.
FRONTIERS IN ONCOLOGY (2017)
Cancer-associated pathways and biomarkers of venous thrombosis
Yohei Hisada et al.
BLOOD (2017)
Methodological Guidelines to Study Extracellular Vesicles
Frank A. W. Coumans et al.
CIRCULATION RESEARCH (2017)
Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice
J. E. Geddings et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Mutant IDH1 and thrombosis in gliomas
Dusten Unruh et al.
ACTA NEUROPATHOLOGICA (2016)
Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?
F. J. Sherida H. Woei-A-Jin et al.
BRITISH JOURNAL OF CANCER (2016)
Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer
Carlota Claussen et al.
THROMBOSIS RESEARCH (2016)
Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models
Yoshiyuki Yamamoto et al.
CANCER SCIENCE (2015)
Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts
Yoshikatsu Koga et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Venous thrombosis and cancer: from mouse models to clinical trials
Y. Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice
G. M. Thomas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors
Esther C. W. Breij et al.
CANCER RESEARCH (2014)
Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice
N. Yokota et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Evaluation of a new commercial assay to measure microparticle tissue factor activity in plasma: communication from the SSC of the ISTH
K. Tatsumi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia
Johannes Thaler et al.
THROMBOSIS RESEARCH (2014)
Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors
Puey Ling Chia et al.
CLINICAL EPIDEMIOLOGY (2014)
Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)
S. Dearden et al.
ANNALS OF ONCOLOGY (2013)
Epidemiology of cancer-associated venous thrombosis
Jasmijn F. Timp et al.
BLOOD (2013)
Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features
Johannes Thaler et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients
Carmen Hernandez et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients
Johannes Thaler et al.
THROMBOSIS RESEARCH (2013)
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers
Anubha Bharthuar et al.
THROMBOSIS RESEARCH (2013)
Critical Review of Mouse Models of Venous Thrombosis
Jose A. Diaz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer
Jian-Guo Wang et al.
BLOOD (2012)
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
J. Thaler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Coagulation activation anc microparticle-associated coagulant activity in cancer patients An exploratory prospective study
Frederiek F. van Doormaal et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity
R. D. Lee et al.
THROMBOSIS RESEARCH (2012)
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
Freesia Horsted et al.
PLOS MEDICINE (2012)
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
Bence Gyoergy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells
Katrin J. Svensson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
Johannes J. A. Auwerda et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient
Lujun Chen et al.
ACTA HISTOCHEMICA (2010)
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma
E. Cocco et al.
BRITISH JOURNAL OF CANCER (2010)
Tissue Factor and Its Measurement in Whole Blood, Plasma, and Microparticles
Nigel S. Key et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
David A. Manly et al.
THROMBOSIS RESEARCH (2010)
Increased Tissue Factor Expression Is Associated with Reduced Survival in Non-Small Cell Lung Cancer and with Mutations of TP53 and PTEN
Sandra Regina et al.
CLINICAL CHEMISTRY (2009)
Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
Grace M. Thomas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Microparticle-associated tissue factor activity in cancer patients with and without thrombosis
M. E. T. Tesselaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation
Florian Langer et al.
ANNALS OF HEMATOLOGY (2008)
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice
Henri H. Versteeg et al.
CANCER RESEARCH (2008)
Tissue factor expression in non-small cell lung cancer:: Relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation
Sandra Regina et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation
M. Davila et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer
Genevieve Patry et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Inhibition of tissue factor signaling suppresses tumor growth
Henri H. Versteeg et al.
BLOOD (2008)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
Alok A. Khorana et al.
CLINICAL CANCER RESEARCH (2007)
Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotype
Hiroharu Yamashita et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
M. E. T. Tesselaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Immunologic quantitation of tissue factors
B. Parhami-Seren et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
A selective tumor microvasculature thrombogen that targets a novel receptor complex in the tumor angiogenic microenvironment
A El-Sheikh et al.
CANCER RESEARCH (2005)
Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma
N Nitori et al.
CLINICAL CANCER RESEARCH (2005)
Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis
JL Yu et al.
BLOOD (2005)
Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells
JL Yu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Tissue factor expression and prognosis in patients with metastatic prostate cancer
T Akashi et al.
UROLOGY (2003)
The tissue factor pathway in disseminated intravascular coagulation
B Osterud et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2001)
Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer
ZW Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy
ZW Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
